Skip to content

ImmuneSpec

Active
Private limited company·Speur- en ontwikkelingswerk op biotechnologisch gebied· 3 yrs active
Galileilaan 18 ·2845 Niel, Belgium
BE 0797.707.610
Watch Print / PDF
Turnover
EBIT margin
Net result€-202k-158.9%
Working capital€991k+21.1%

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of ImmuneSpec is 0.9% (low). The 2025 annual accounts show equity of €2.64M and a net result of €-202k. The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 2 annual accounts.

Connections

6 connected companies
Heran Partners
Parent · 5 subsidiaries · 1 location
Control
All 6 connections

Trust signals

3 signals
More than 3 years active
Founded in 2023 — past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).

Administrative Flags

0 events
No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.9% Low
0%0,5%1,5%4%10%≥25%
Young company +Lower-failure-rate sector Annual accounts: healthy financial profile

Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?

Company registry (CBE)

Crossroads Bank
Activities
Speur- en ontwikkelingswerk op biotechnologisch gebied72101Speur- en ontwikkelingswerk op biotechnologisch gebied72110
Primary activity highlighted.
Names & trade names
Legal nameNL ImmuneSpec
Registered office
Galileilaan 18 bus 6
2845 Niel, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.